VAERS Explorer
Back to explore

Report #2838974

Received Apr 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Apr 29, 2025
Onset
Apr 29, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RV5ROTAVIRUS (ROTATEQ)MERCK & CO. INC.UNK2091232OT

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

No other AE.; third dose of ROTATEQ past the recommended age.; This spontaneous report was received from a health care professional referring to a 9-months-old patient, gender not reported. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 29-APR-2025, at the age of 9 months, the patient was vaccinated with the third dose of Rotavirus Vaccine, Live, Oral, Pentavalent Oral solution (ROTATEQ) liquid, (valid lot number 2091232, with an expiration date on 17-APR-2026) administered orally for prophylaxis. (Product administered to patient of inappropriate age).